- Home
- INTU vs MRK Comparison
INTU vs MRK Comparison
Compare INTU & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTU
- MRK
- Stock Information
- Founded
- INTU 1983
- MRK 2000
- Country
- INTU United States
- MRK United States
- Employees
- INTU N/A
- MRK N/A
- Industry
- INTU Computer Software: Prepackaged Software
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- INTU Technology
- MRK Health Care
- Exchange
- INTU Nasdaq
- MRK Nasdaq
- Market Cap
- INTU 213.2B
- MRK 198.5B
- IPO Year
- INTU 1993
- MRK N/A
- Fundamental
- Price
- INTU $791.51
- MRK $81.00
- Analyst Decision
- INTU Buy
- MRK Buy
- Analyst Count
- INTU 20
- MRK 15
- Target Price
- INTU $795.90
- MRK $113.71
- AVG Volume (30 Days)
- INTU 1.6M
- MRK 18.0M
- Earning Date
- INTU 08-21-2025
- MRK 07-29-2025
- Dividend Yield
- INTU 0.53%
- MRK 4.00%
- EPS Growth
- INTU 13.03
- MRK 667.14
- EPS
- INTU 12.24
- MRK 6.88
- Revenue
- INTU $18,184,000,000.00
- MRK $63,922,000,000.00
- Revenue This Year
- INTU $17.45
- MRK $2.42
- Revenue Next Year
- INTU $12.43
- MRK $5.77
- P/E Ratio
- INTU $63.78
- MRK $11.77
- Revenue Growth
- INTU 14.99
- MRK 4.10
- 52 Week Low
- INTU $532.65
- MRK $73.31
- 52 Week High
- INTU $790.60
- MRK $129.93
- Technical
- Relative Strength Index (RSI)
- INTU 65.43
- MRK 54.36
- Support Level
- INTU $765.81
- MRK $78.14
- Resistance Level
- INTU $790.60
- MRK $83.07
- Average True Range (ATR)
- INTU 12.15
- MRK 1.84
- MACD
- INTU -2.62
- MRK 0.21
- Stochastic Oscillator
- INTU 75.24
- MRK 64.15
About INTU Intuit Inc.
Intuit serves small and midsize businesses with accounting software QuickBooks and online marketing platform Mailchimp. The company also operates retail tax filing tool TurboTax, personal finance platform Credit Karma, and a suite of professional tax offerings for accountants. Founded in the mid-1980s, Intuit enjoys a dominant market share for small business accounting and do-it-yourself tax filing in the US.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.